Smoking cessation is associated with reduced long-term mortality and the need for repeat interventions after coronary

Athanasios Papathanasiou1, Haralampos Milionis, Ioannis Toumpoulis

  • 1Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.

Insights

Smoking cessation after coronary artery bypass grafting (CABG) significantly reduces long-term mortality and the need for repeat procedures. Continued smoking post-CABG is linked to increased cardiovascular death and revascularization needs.

Area of Science:

  • Cardiology
  • Public Health
  • Thoracic Surgery

Background:

  • Coronary artery bypass grafting (CABG) is a common procedure for severe coronary artery disease.
  • Smoking is a major risk factor for cardiovascular disease and impacts surgical outcomes.
  • The long-term effects of continued smoking versus cessation after CABG require further elucidation.

Purpose of the Study:

  • To assess the impact of smoking cessation on long-term mortality after CABG.
  • To evaluate the effect of smoking status on the need for repeat revascularization procedures post-CABG.

Main Methods:

  • Prospective study design.
  • Inclusion of 1027 patients undergoing their first-ever CABG.
  • Follow-up over 5310 patient-years, comparing current smokers, quitters, and never smokers.

Main Results:

  • Among 640 active smokers, 44.7% continued smoking post-CABG.
  • Current smokers, compared to never smokers, showed a 2.6-fold increased risk of total mortality and a 4.8-fold increased risk of cardiovascular mortality.
  • Current smokers also had a 1.7-fold increased risk of requiring a repeat revascularization procedure.

Conclusions:

  • Smoking cessation after CABG is associated with improved long-term survival.
  • Continued smoking post-CABG significantly increases mortality, particularly cardiovascular mortality.
  • Smoking cessation is crucial for reducing the need for repeat revascularization procedures in CABG patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...